NewcelX Ltd.
NewcelX Ltd. (NCEL): ~3 mo cash runway. Updated within the last hour.
BioSniper Score
3-factor signal · derived from public data
2.7 months
D/E 0.58 · 0% dilution
N/A
N/A
N/A
2 buys · 0 sells (180d)
A transparent, data-derived signal for NewcelX Ltd.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$17.3M
Cash
$2.2M
Quarterly Burn
$2.8M
Runway
2.7 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
1
Total value held
$6
| Holder | Shares | Value |
|---|---|---|
| corecap advisors, llc | 3 | $6 |
Frequently asked questions
What is NewcelX Ltd.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, NewcelX Ltd. has approximately 2.7 months of cash runway.
What is NewcelX Ltd.'s market capitalization?
NewcelX Ltd.'s market capitalization is approximately $17.3M.
Who is the CEO of NewcelX Ltd.?
Mr. Ronen Twito CPA is the chief executive officer of NewcelX Ltd. (NCEL).
Get the full picture on NewcelX Ltd.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.